Crohn's Disease with Normal Colonoscopy and Recurrent Perianal Fistulas
Yes, it is possible for a patient to have Crohn's disease with a normal colonoscopy and recurrent perianal fistulas as the only manifestation. This presentation represents a distinct subset of Crohn's disease that can be challenging to diagnose and manage.
Epidemiology and Presentation
Perianal fistulas occur in approximately 14-38% of patients with Crohn's disease 1. Notably:
- Perianal fistulas can precede or appear simultaneously with the diagnosis of intestinal Crohn's disease in 36-81% of patients who develop perianal disease 1
- A small proportion of patients with Crohn's disease may persist in having only isolated perianal involvement 1
- The risk of developing perianal fistulas varies by disease location:
- 12% in ileal disease
- 15% in ileocolonic disease
- 41% in colonic disease with rectal sparing
- 92% in colonic disease with rectal involvement 1
Diagnostic Considerations
When encountering a patient with recurrent perianal fistulas and normal colonoscopy findings, consider:
Cross-sectional imaging: MRI enterography or CT enterography should be performed to evaluate for small bowel involvement that may be beyond the reach of colonoscopy 1
Comprehensive perianal assessment:
- Contrast-enhanced pelvic MRI is considered the initial procedure for assessment of perianal fistulizing Crohn's disease 1
- Examination under anesthesia (EUA) is considered the gold standard for evaluating perianal fistulas 1
- Endoscopic anorectal ultrasound is a good alternative if rectal stenosis is excluded 1
Classification of fistulas:
- Simple fistulas: low (superficial or low intersphincteric or low transsphincteric), single external opening, no pain/fluctuation, no rectovaginal fistula, no anorectal stricture 1
- Complex fistulas: high (high intersphincteric, high transsphincteric, extrasphincteric, or suprasphincteric), may have multiple external openings, associated with pain/abscess/rectovaginal fistula/anorectal stricture 1
Management Approach
For patients with recurrent perianal fistulas and normal colonoscopy:
Initial management:
Medical therapy:
- Infliximab is strongly recommended for patients with perianal fistulizing Crohn's disease 2
- Higher infliximab trough levels (>10 μg/mL) may be beneficial specifically for perianal fistulizing disease 2
- Consider combination therapy with an immunomodulator (azathioprine/6-mercaptopurine) to reduce immunogenicity and improve outcomes 2
Surgical options:
Monitoring and Prognosis
Despite optimal management, outcomes can be challenging:
- In a multicenter case series of isolated complex perianal fistulas, despite surgical and/or medical management, active symptomatic fistulas persisted in 58% of patients at follow-up (median 5.5 years) 3
- Symptom remission was achieved in only 21%, and complete fistula closure in 21% 3
- Regular assessment of fistula drainage, inflammatory markers, and clinical symptoms is essential 2
Important Caveats
Disease progression: Isolated perianal fistulas may represent an early presentation of Crohn's disease that could later manifest with intestinal involvement 3
Cancer risk: Long-standing perianal Crohn's disease carries a risk of malignancy, necessitating monitoring 1
Diagnostic challenges: Distinguishing between isolated cryptoglandular fistulas and Crohn's disease with isolated perianal manifestation can be difficult 3
Treatment resistance: Perianal fistulas in Crohn's disease often require multiple surgical interventions and have high recurrence rates 4
In summary, while uncommon, Crohn's disease can present with normal colonoscopy findings and recurrent perianal fistulas as the only manifestation. This presentation requires thorough evaluation with cross-sectional imaging and perianal assessment, followed by a combined medical-surgical approach to management.